SEC Form 4 · accession 0001171843-16-011741
IMMUNOMEDICS INC · IMMU
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Don C Stark
Director
Period of report
Aug 10, 2016
Accepted (ET)
Aug 12, 2016 · 4:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000722830
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 10, 2016 | M | 15,000 | $1.96 | A | 65,748 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy)F1 | $1.96 | Aug 10, 2016 | M | 15,000 | D | — | Aug 23, 2016 | Common Stock, par value $0.01 per share | 15,000 | 0 | D |
Explanation of responses
- F1The stock options are fully vested on the date of grant.